What does MEDICAL SERVAES do?

MEDICAL SERVAES is a specialist medical practice in Chaumont-Gistoux. Private Limited, started on 6 October 2011, 1 establishment.

What is the address of MEDICAL SERVAES?

The registered office of MEDICAL SERVAES is located at Rue des Boissonnets 7, 1325 Chaumont-Gistoux.

Is MEDICAL SERVAES still active?

Yes. According to the CBE (17 September 2026) MEDICAL SERVAES is active, legal situation “Normale toestand”, started on 6 October 2011.

Is MEDICAL SERVAES registered on Peppol?

Yes, MEDICAL SERVAES is registered on the Peppol network with ID 0208:0840193115.

What is the enterprise number of MEDICAL SERVAES?

The enterprise number of MEDICAL SERVAES is BE0840193115.

When was MEDICAL SERVAES founded?

MEDICAL SERVAES was founded on 6 October 2011.

Who are the directors of MEDICAL SERVAES?

According to the 2025 annual accounts, the directors of MEDICAL SERVAES are: Maxime Servaes.

Is MEDICAL SERVAES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 October 2011; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDICAL SERVAES make in 2025?

MEDICAL SERVAES posted a profit after taxes of € 103,830 in financial year 2025.

What is the revenue of MEDICAL SERVAES?

As a small company, MEDICAL SERVAES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 241,579.

MEDICAL SERVAES (Private Limited) - Chaumont-Gistoux

Dossier MEDICAL SERVAES, printed on 17 September 2026 from databakkes.be/en/0840193115/medical-servaes. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDICAL SERVAES from Chaumont-Gistoux, company number BE0840193115, closed financial year 2025 with a result of € 103,830 after tax. For that financial year MEDICAL SERVAES recorded a gross margin of € 241,579 and equity of € 598,343. Compared with financial year 2024, the result moved from € 100,011 to € 103,830. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.

What it is worth Growing

€ 598,343

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 103,830

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 51,234

▲ 108% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 38,000 paid out

37 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 1,220

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 155,413

▲ 20% vs 2024

Of which on lease € 65,976.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 941,143

▲ 35% vs 2024

€ 165,335 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 54,004

▲ € 42,164 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 4,256

▼ 80% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 188,982 Gross margin 2021: € 188,982 First fiscal year in the series	€ 206,617 Gross margin 2023: € 206,617 ▲ 9% vs 2021 (€ 188,982) Favourable step	€ 232,812 Gross margin 2024: € 232,812 ▲ 13% vs 2023 (€ 206,617) Favourable step	€ 241,579 Gross margin 2025: € 241,579 ▲ 4% vs 2024 (€ 232,812) Favourable step	▲ 4%
Profit after taxes	€ 86,266 Profit after taxes 2021: € 86,266 First fiscal year in the series	€ 82,863 Profit after taxes 2023: € 82,863 ▼ 4% vs 2021 (€ 86,266) Unfavourable step	€ 100,011 Profit after taxes 2024: € 100,011 ▲ 21% vs 2023 (€ 82,863) Favourable step	€ 103,830 Profit after taxes 2025: € 103,830 ▲ 4% vs 2024 (€ 100,011) Favourable step	▲ 4%
Equity	€ 402,602 Equity 2021: € 402,602 First fiscal year in the series	€ 500,502 Equity 2023: € 500,502 ▲ 24% vs 2021 (€ 402,602) Favourable step	€ 532,513 Equity 2024: € 532,513 ▲ 6% vs 2023 (€ 500,502) Favourable step	€ 598,343 Equity 2025: € 598,343 ▲ 12% vs 2024 (€ 532,513) Favourable step	▲ 12%
Total debts	€ 738,445 Total debts 2021: € 738,445 First fiscal year in the series	€ 869,145 Total debts 2023: € 869,145 ▲ 18% vs 2021 (€ 738,445) Unfavourable step	€ 802,448 Total debts 2024: € 802,448 ▼ 8% vs 2023 (€ 869,145) Favourable step	€ 1,039,919 Total debts 2025: € 1,039,919 ▲ 30% vs 2024 (€ 802,448) Unfavourable step	▲ 30%
Cash	€ 65,970 Cash 2021: € 65,970 First fiscal year in the series	-	€ 24,680 Cash 2024: € 24,680 First fiscal year in the series	€ 51,234 Cash 2025: € 51,234 ▲ 108% vs 2024 (€ 24,680) Favourable step	▲ 108%
Land & buildings	€ 788,865 Land & buildings 2021: € 788,865 First fiscal year in the series	€ 850,287 Land & buildings 2023: € 850,287 ▲ 8% vs 2021 (€ 788,865) Unchanged	€ 829,593 Land & buildings 2024: € 829,593 ▼ 2% vs 2023 (€ 850,287) Unchanged	€ 1,095,715 Land & buildings 2025: € 1,095,715 ▲ 32% vs 2024 (€ 829,593) Unchanged	▲ 32%
Retained profit	€ 390,202 Retained profit 2021: € 390,202 First fiscal year in the series	€ 488,102 Retained profit 2023: € 488,102 ▲ 25% vs 2021 (€ 390,202) Favourable step	€ 520,113 Retained profit 2024: € 520,113 ▲ 7% vs 2023 (€ 488,102) Favourable step	€ 585,943 Retained profit 2025: € 585,943 ▲ 13% vs 2024 (€ 520,113) Favourable step	▲ 13%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 65,000 Dividend 2023: € 65,000 Unchanged (€ 0) Unchanged	€ 68,000 Dividend 2024: € 68,000 ▲ 5% vs 2023 (€ 65,000) Unchanged	€ 38,000 Dividend 2025: € 38,000 ▼ 44% vs 2024 (€ 68,000) Unchanged	▼ 44%
Bank debt	€ 643,241 Bank debt 2021: € 643,241 First fiscal year in the series	€ 775,262 Bank debt 2023: € 775,262 ▲ 21% vs 2021 (€ 643,241) Unfavourable step	€ 698,797 Bank debt 2024: € 698,797 ▼ 10% vs 2023 (€ 775,262) Favourable step	€ 941,143 Bank debt 2025: € 941,143 ▲ 35% vs 2024 (€ 698,797) Unfavourable step	▲ 35%
Balance sheet total	€ 1,141,047 Balance sheet total 2021: € 1,141,047 First fiscal year in the series	€ 1,369,648 Balance sheet total 2023: € 1,369,648 ▲ 20% vs 2021 (€ 1,141,047) Unchanged	€ 1,334,961 Balance sheet total 2024: € 1,334,961 ▼ 3% vs 2023 (€ 1,369,648) Unchanged	€ 1,638,262 Balance sheet total 2025: € 1,638,262 ▲ 23% vs 2024 (€ 1,334,961) Unchanged	▲ 23%

Key figures of MEDICAL SERVAES, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to MEDICAL SERVAES?

What happened at MEDICAL SERVAES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 28, 2026 New annual accounts for financial year 2025: profit of € 103,830 (▲ 4% vs 2024). Source: NBB ↗
Oct 6, 2011 New establishment in Chaumont-Gistoux. KBO
Oct 6, 2011 Start of the company according to the CBE. KBO

In short

From € 86,266 profit in 2021 to € 103,830 profit in 2025.

Paid € 158,876 in corporate taxes since 2021.

Best year ever: 2025, with € 103,830 profit.

Paid out € 171,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MEDICAL SERVAES? We notify you, reason included.

Follow MEDICAL SERVAES

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Maxime Servaes

MEDICAL SERVAES

MBVS 50%

Behind MEDICAL SERVAES is Maxime Servaes. It owns 50% of MBVS itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Maxime Servaes

Director

Also active at: MBVS

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Boissonnets 7

1325 Chaumont-Gistoux

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MBVS same network

€ -15,988 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0840.193.115
VAT number: BE 0840.193.115
Registered office: Rue des Boissonnets 7, 1325 Chaumont-Gistoux
Names & denominations: MEDICAL SERVAES
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 October 2011
Peppol: Active · Active since 18 Feb 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗